Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · IEX Real-Time Price · USD
16.78
-0.71 (-4.06%)
At close: Apr 25, 2024, 4:00 PM
17.95
+1.17 (6.97%)
Pre-market: Apr 26, 2024, 8:05 AM EDT
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $785.39 million as of April 26, 2024. Its market cap has increased by 507.89% in one year.
Market Cap
785.39M
Enterprise Value
532.19M
1-Year Change
507.89%
Ranking
Category
Stock Price
$16.78
Market Cap Chart
Since March 12, 2020, Enliven Therapeutics's market cap has increased from $244.90M to $785.39M, an increase of 220.70%. That is a compound annual growth rate of 32.69%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 723.20M | 0.70% |
Apr 23, 2024 | 718.20M | -1.41% |
Apr 22, 2024 | 728.50M | 1.96% |
Apr 19, 2024 | 714.50M | -2.20% |
Apr 18, 2024 | 730.60M | 2.14% |
Apr 17, 2024 | 715.30M | -7.44% |
Apr 16, 2024 | 772.80M | -6.27% |
Apr 15, 2024 | 824.50M | -5.40% |
Apr 12, 2024 | 871.60M | -11.50% |
Apr 11, 2024 | 984.90M | 20.18% |
Apr 10, 2024 | 819.50M | 3.28% |
Apr 9, 2024 | 793.50M | 4.86% |
Apr 8, 2024 | 756.70M | -5.66% |
Apr 5, 2024 | 802.10M | 4.29% |
Apr 4, 2024 | 769.10M | 0.05% |
Apr 3, 2024 | 768.70M | -1.11% |
Apr 2, 2024 | 777.30M | -0.54% |
Apr 1, 2024 | 781.50M | 7.45% |
Mar 28, 2024 | 727.30M | -5.58% |
Mar 27, 2024 | 770.30M | 5.80% |
Mar 26, 2024 | 728.10M | -0.97% |
Mar 25, 2024 | 735.20M | -3.78% |
Mar 22, 2024 | 764.10M | 2.33% |
Mar 21, 2024 | 746.70M | -5.99% |
Mar 20, 2024 | 794.30M | 9.53% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Zentalis Pharmaceuticals | 835.20M |
Relay Therapeutics | 832.99M |
Tango Therapeutics | 828.13M |
Healthcare Services Group | 825.60M |
EyePoint Pharmaceuticals | 820.71M |
Viridian Therapeutics | 817.86M |
National Research | 817.49M |
Canopy Growth | 817.30M |